StockData
Biogen Inc. logo

Biogen Inc.

BIIBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3055% above fair value
$247.13−4.28 (-1.70%)

Close on Nov 19, 2026Market cap $36.53BP/E 105.6Yield –

Biogen Non-GAAP Cost of Sales by Quarter

Non-GAAP Cost of Sales (Excl. Acquired Intangible Amortization) ($M)

Biogen Non-GAAP Cost of Sales: $553M in Q3 2026, up 8.3% from a year earlier.

Latest, Q3 2026
553
Period ended Sep 30, 2026
Change on a year earlier
+8.3%
510 in Q3 2025
History
14 quarters
Since Q4 2022
Sources
10
Documents cited below

Where the Q3 2026 figure comes from

Source: Biogen Form 8-K (filed 2026-10-28) ↗

Reported in Form 8-K Table 4 (GAAP to Non-GAAP Reconciliation).

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP Cost of Sales (Excl. Acquired Intangible Amortization) ($M)Year on yearSource
Q3 2026Sep 30, 2026553+8.3%Biogen Form 8-K (filed 2026-10-28) ↗
Q2 2026Jun 30, 2026612+10.4%Biogen Form 8-K (filed 2026-07-29) ↗
Q1 2026Mar 31, 2026610+5.2%Biogen Form 8-K (filed 2026-04-29) ↗
Q3 2025Sep 30, 2025510-13.9%Biogen Form 8-K (filed 2025-10-30) ↗
Q2 2025Jun 30, 2025554+10.0%Biogen Form 8-K (filed 2025-07-31) ↗
Q1 2025Mar 31, 2025580+16.0%Biogen Form 8-K (filed 2025-05-01) ↗
Q3 2024Sep 30, 2024593-10.2%Biogen Form 8-K (filed 2024-10-30) ↗
Q2 2024Jun 30, 2024504-15.0%Biogen Form 8-K (filed 2024-08-01) ↗
Q1 2024Mar 31, 2024500-24.6%Biogen Form 8-K (filed 2024-04-24) ↗
Q4 2023Dec 31, 2023587+2.8%Biogen Form 8-K (filed 2024-02-13) ↗
Q3 2023Sep 30, 2023660–Biogen Form 8-K (filed 2024-10-30) ↗
Q2 2023Jun 30, 2023593–Biogen Form 8-K (filed 2024-08-01) ↗
Q1 2023Mar 31, 2023663–Biogen Form 8-K (filed 2024-04-24) ↗
Q4 2022Dec 31, 2022571–Biogen Form 8-K (filed 2024-02-13) ↗

Breakdown

What makes up non-GAAP Cost of Sales

Cite this data

StockData. (2026). Biogen Non-GAAP Cost of Sales ($M), quarterly Q4 2022–Q3 2026 [Data set]. Compiled from Biogen SEC filings and investor materials. https://stockdatahq.com/stocks/biib/kpis/ng-cogs

See every metric in the Biogen KPI table. Data updated Nov 10, 2026.

See a number that looks wrong?